(Q53572523)
Statements
A randomised study in healthy volunteers to investigate the safety, tolerability and pharmacokinetics of idarucizumab, a specific antidote to dabigatran. (English)
Stephan Glund
Viktoria Moschetti
Stephen Norris
Joachim Stangier
Michael Schmohl
Joanne van Ryn
Benjamin Lang
Steven Ramael
Paul Reilly
19 March 2015
113
5
943-951